High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronar... von CUISSET, T., FRERE, C., QUILICI, J., BARBOU, F., MORANGE, P. E., HOVASSE, T., BONNET, J‐L., ALESSI, M‐C.

Volltext

Current knowledge on the genetics of incident venous thrombosis von Morange, P.‐E., Trégouët, D.‐A.

Volltext

Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring von Susen, Sophie, Tacquard, Charles Ambroise, Godon, Alexandre, Mansour, Alexandre, Garrigue, Delphine, Nguyen, Philippe, Godier, Anne, Testa, Sophie, Levy, Jerrold H, Albaladejo, Pierre, Gruel, Yves

Volltext

Endothelial cell markers and the risk of coronary heart disease: The prospective epidemiological study of myocardial infarction (PRIME) study von MORANGE, P. E, SIMON, C, ALESSI, M. C, LUC, G, ARVEILER, D, FERRIERES, J, AMOUYEL, P, EVANS, A, DUCIMETIERE, P, JUHAN-VAGUE, I

Volltext

The missing heritability of venous thrombosis: what about factor V Leiden heterogeneity? von Fautrad, P., Thomas, G. M., Morange, P. E.

Volltext

Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism von Dennis, J., Truong, V., Aïssi, D., Medina‐Rivera, A., Blankenberg, S., Germain, M., Lemire, M., Antounians, L., Civelek, M., Schnabel, R., Wells, P., Wilson, M. D., Morange, P.‐E., Trégouët, D.‐A., Gagnon, F.

Volltext

Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat von Gaborit, B, Kober, F, Jacquier, A, Moro, P J, Cuisset, T, Boullu, S, Dadoun, F, Alessi, M-C, Morange, P, Clément, K, Bernard, M, Dutour, A

Volltext

Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk von Juhan‐Vague, I., Alessi, M‐C., Mavri, A., Morange, P. E.

Volltext

Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study von Suchon, P., Al Frouh, F., Ibrahim, M., Sarlon, G., Venton, G., Alessi, M.‐C., Trégouët, D.‐A., Morange, P.‐E.

Volltext

Heparin-induced thrombocytopenia: Update von Camoin-Jau, L, Mariotti, A, Suchon, P, Morange, P-E

Volltext

Is there still room for additional common susceptibility alleles for venous thromboembolism? von Trégouët, D. A., Delluc, A., Roche, A., Derbois, C., Olaso, R., Germain, M., Andrade, M., Tang, W., Chasman, D. I., Hylckama Vlieg, A., Reitsma, P. H., Kabrhel, C., Smith, N., Morange, P. E.

Volltext

Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation von Ibrahim-Kosta, M., Suchon, P., Couturaud, F., Smadja, D., Olaso, R., Germain, M., Saut, N., Goumidi, L., Derbois, C., Thibord, F., Debette, S., Amouyel, P., Deleuze, J. F., van Doorn, P., Castoldi, E., Patin, E., Alessi, M. C., Trégouët, D. A., Morange, P. E.

Volltext

Lessons from genome‐wide association studies in venous thrombosis von MORANGE, P. E., TREGOUET, D. A.

Volltext

α1‐antitrypsin Pittsburgh and plasmin‐mediated proteolysis von Henneuse, A., Suchon, P., Chambost, H., Morange, P. E., Frere, C., Alessi, M. C.

Volltext

Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels von MORANGE, P.‐E., SAUT, N., ANTONI, G., EMMERICH, J., TRÉGOUËT, D.‐A.

Volltext

Association of Plasminogen Activator Inhibitor (PAI)-1 (SERPINE1) SNPs With Myocardial Infarction, Plasma PAI-1, and Metabolic Parameters: The HIFMECH Study von Morange, P E, Saut, N, Alessi, M C, Yudkin, J S, Margaglione, M, Di Minno, G, Hamsten, A, Humphries, S E, Tregouet, D A, Juhan-Vague, I

Volltext

Haemostatic Factors and the Risk of Cardiovascular Death in Patients With Coronary Artery Disease: The AtheroGene Study von Morange, P E, Bickel, C, Nicaud, V, Schnabel, R, Rupprecht, H J, Peetz, D, Lackner, K J, Cambien, F, Blankenberg, S, Tiret, L

Volltext

A multi‐stage multi‐design strategy provides strong evidence that the BAI3 locus is associated with early‐onset venous thromboembolism von ANTONI, G., MORANGE, P.‐E., LUO, Y., SAUT, N., BURGOS, G., HEATH, S., GERMAIN, M., BIRON‐ANDREANI, C., SCHVED, J.‐F., PERNOD, G., GALAN, P., ZELENIKA, D., ALESSI, M.‐C., DROUET, L., VISVIKIS‐SIEST, S., WELLS, P. S., LATHROP, M., EMMERICH, J., TREGOUET, D.‐A., GAGNON, F.

Volltext

Targeted sequencing to identify novel genetic risk factors for deep vein thrombosis: a study of 734 genes von Haan, H. G., Hylckama Vlieg, A., Lotta, L. A., Gorski, M. M., Bucciarelli, P., Martinelli, I., Baglin, T. P., Peyvandi, F., Rosendaal, F. R., Amouyel, P., Andrade, M., Basu, S., Berr, C., Brody, J. A., Chasman, D. I, Dartigues, J.‐F., Folsom, A. R., Germain, M., Heit, J., Houwing‐Duitermaat, J., Kabrhel, C., Kraft, P., Le Gal, G., Lindström, S., Monajemi, R., Morange, P.‐E., Psaty, B. M., Reitsma, P. H., Ridker, P. M., Rose, L. M., Saut, N., Slagboom, E., Smadja, D., Smith, N. L., Suchon, P., Tang, W., Taylor, K. D., Trégouët, D.‐A., Tzourio, C., Visser, M. C. H., Weng, L.‐C., Wiggins, K. L.

Volltext

Peripartum bleeding management in a patient with CalDAG‐GEFI deficiency von Canault, M., Saultier, P., Fauré, S., Poggi, M., Nurden, A. T, Nurden, P., Morange, P. E., Alessi, M‐C., Gris, J‐C.

Volltext